Skip to main content
TITAN PHARMACEUTICALS INC logo

TITAN PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · TTNP ISIN · US8883146065 LEI · 549300NOUZGB2ZNVJ794 US Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2020-12-15 Regulatory Filings
Country US United States of America
Listing US TTNP

About TITAN PHARMACEUTICALS INC

https://www.titanpharm.com/

Titan Pharmaceuticals, Inc. is a development-stage biopharmaceutical company that develops proprietary therapeutics using its clinically proven ProNeura® technology, a long-term, continuous drug delivery platform. This platform is designed for the administration of medicines to treat select chronic diseases. The ProNeura system involves a small, solid implant that is placed subdermally and provides continuous, non-fluctuating blood levels of a drug for an extended period. The company's development efforts have historically focused on treatments for central nervous system disorders.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2020
Regulatory Filings Classification · 60% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or fiscal period dates that would allow identification of a specific filing type. There is no indication of report titles, financial data, or announcements. Given the lack of discernible information and the fallback rule, the document should be classified as a Regulatory Filing (RNS). The confidence is moderate due to the inability to extract meaningful content.
2020-12-15 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Securities and Exchange Commission requesting acceleration of the effective date of a Registration Statement on Form S-1. It is a correspondence related to a regulatory filing process, specifically about the registration statement effectiveness, not the registration statement itself or any financial report. The document is short (1522 characters) and does not contain financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and correspondence with regulatory bodies.
2020-12-14 English
FORM S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used by companies to register securities for public offering. It includes detailed information about the company, the securities being offered, risk factors, use of proceeds, and other disclosures required for an initial or secondary public offering. The presence of terms like 'Registration Statement,' 'Securities Act of 1933,' 'prospectus,' and detailed offering information confirms this is a capital raising filing. This is not an annual or quarterly report, earnings release, or any other type of report listed in the definitions. The closest matching category is 'Capital/Financing Update (CAP)' which covers updates on company fundraising and financing activities. The document length and content confirm it is the actual registration statement, not just an announcement of a report. Therefore, the correct classification is CAP with high confidence.
2020-12-08 English
FORM 8-K
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The key content is about a notice of delisting from Nasdaq due to failure to meet the minimum bid price requirement, and the company's actions to appeal and rectify the situation. This is a regulatory announcement about the potential removal of the company's stock from the exchange. The document is not a full financial report, earnings release, or management discussion, but rather a formal notice of delisting proceedings. Therefore, the appropriate classification is 'Delisting Announcement' (DLST). The document length is 3852 characters, which is consistent with a typical 8-K notice rather than a full report.
2020-12-03 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a proxy statement or related materials filed pursuant to the Securities Exchange Act of 1934. It specifically mentions 'Definitive additional materials' related to a proxy statement for an annual stockholders meeting. The content discusses amendments to the equity incentive plan and proxy solicitation details, which are typical contents of proxy solicitation materials. The document length is 3472 characters, which is relatively short and consistent with additional proxy materials rather than a full report. Therefore, this document fits the category of Proxy Solicitation & Information Statement (PSI).
2020-12-02 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC by Titan Pharmaceuticals, Inc. It details a reverse stock split of the company's common stock, including the filing of a Certificate of Amendment and the voting results from a special meeting of stockholders. The content focuses on amendments to the articles of incorporation and changes in stock structure, not on financial results or earnings. There is no detailed financial data or comprehensive report content, but rather an announcement of corporate actions and voting outcomes. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fall under more specific categories like Capital/Financing Update or Share Issue/Capital Change, since it primarily reports the amendment and voting results rather than a financing event or new share issuance. The document length and detail also support this classification rather than a brief announcement (RPA).
2020-12-01 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.